| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |